发明授权
US5522798A Control of a multi-channel drug infusion pump using a pharmacokinetic
model
失效
使用药代动力学模型控制多通道药物输注泵
- 专利标题: Control of a multi-channel drug infusion pump using a pharmacokinetic model
- 专利标题(中): 使用药代动力学模型控制多通道药物输注泵
-
申请号: US324392申请日: 1994-10-17
-
公开(公告)号: US5522798A公开(公告)日: 1996-06-04
- 发明人: Noel L. Johnson , Jyh-yi T. Huang , Tao Chang
- 申请人: Noel L. Johnson , Jyh-yi T. Huang , Tao Chang
- 申请人地址: IL Abbott Park
- 专利权人: Abbott Laboratories
- 当前专利权人: Abbott Laboratories
- 当前专利权人地址: IL Abbott Park
- 主分类号: A61M5/168
- IPC分类号: A61M5/168 ; A61M5/172 ; A61M31/00
摘要:
A host controller (10) selectively predicts and controls drug concentrations for each of a plurality of channels delivered through multiple drug channels of a multi-channel drug delivery system. The host controller includes a controller (32) that is coupled to each drug channel of the multi-channel drug delivery system to receive actual drug delivery rate information. Delivery of each drug can be selectively separately controlled by a PK model (the same PK model for each channel or different PK models for different channels) to achieve either a desired setpoint for a blood plasma drug concentration or a setpoint for an effect compartment drug concentration. Control of the drug delivery by the PK model can be selectively interrupted during operation of the multi-channel drug delivery system, to switch to a manual mode in order to administer a bolus dose or a continuous infusion, and then, control of drug infusion using the PK model can be subsequently resumed. The blood plasma and/or effect compartment drug concentrations for any drug predicted in accordance with a PK model are selectively displayed to a user on an electroluminescent (EL) display (36), even during operation of the multi-channel drug delivery system in the manual mode, or after the drug delivery has been terminated. Prediction of drug concentration is tracked for each drug administered, enabling multiple drugs to successively administered in the same drug channel and control of a drug delivery by the PK model to continue when the drug channel used to administer the drug is changed.
公开/授权文献
- US4408249A Totally enclosed surge arrester 公开/授权日:1983-10-04
信息查询
IPC分类: